superduperinvst
@superduperinvst
Bio · written by the author
This creator specialises in unearthing deeply undervalued small-cap and micro-cap stocks — particularly in biotech and emerging tech — before institutional money arrives, aiming to get followers in at ground-floor prices ahead of major catalysts like FDA decisions or buyout events. Known for coining the term 'PAYtience,' they advocate a disciplined buy-on-dips, hold-for-the-catalyst approach that has produced several high-profile multi-hundred-percent wins. They also flag overvalued momentum names as short candidates, providing a contrarian perspective across both sides of the market.
ANTE Score
Building
11/20
9 more settled calls before this record earns a number. At the current rate, that is Jan 13.
11
settled calls
4
still open
40
calls posted
Counts, not a rate. 11 settled calls is too small a sample to look proven.
Free · 3 follows · one push per new call.
1-week read
Provisional▲ +0.4% (+0.7% vs mkt) over 20 calls. Unverified, not part of any score, and not on the leaderboard.
The record so far
40 on the record · 28 active · 9 wins · 2 losses · every call →
Showing 38 receipts of 40 calls — every call →
Sep 30, 26 · entry 1.65 · open · 21d
Load up this thin float disruptive anti-cancer play. Accumulating and see huge upside potential in ST/NT & LT. | Fearlessly buying this Nasdaq listed CANCER play on dips to sell someday at much higher prices as I see spike to $5 - $25 with vision & PAYtience. Stock has tendency to suddenly liftoff like 🚀. Anti CANCER Disruptive with huge growth potential as it keeps winning approvals and penetration in major markets globally. IceCure has developed minimally-invasive cryoablation technology that destroys tumors by freezing as an option to surgical tumor removal. It offers US FDA approved miniminally invasive cyroblation procedure that serves as an attractive alternative to traditional lumpectomy/surgery for Breast Cancer battling elderly women. Company reported 45% higher sales in 1st half of this year on YoY basis. Current mkt cap - $6 mln. Cash on hand - $12 mln (June end). Equity float: 2.52 mln shares. Outstanding: 4.64 mln shares. Company is transitioning from clinical validation
Sep 30, 26 · entry 4.2101 · open · 21d
Load up on dips. See it rising to $5 to $25 in NT/LT.
Sep 29, 26 · entry 5.135 · open · 22d
~$300 mln company valuation = SCREAMING BUY for investors with vision & PAYtience. Based on following, company's valuation currently should be anywhere between $650 mln to $1.6 bln imo. 2026 projected sales per mgmt: $240 – $290 mln. Cash on hand ~$175 mln.
Sep 25, 26 · entry 4.95 · open · 26d
Undervalued with significant catalysts, including product launches and clinical readouts through H1 2027. Squeeze on low market cap. Targets 15-50. Buying on dips and holding for long-term potential.
Sep 23, 26 · entry 5 · open · 28d
Investors with vision and PAYtience should load up and add fearlessly if there are any dips. This stock will make a lot of money in the future over the time in ST/NT/LT.
Sep 23, 26 · entry 3.15 · open · 28d
Load up and add on any further dips. Believed to be between $6.25 - $15 range by the end of this year. | Investors with vision and PAYtience should load up and add fearlessly if there are any dips. This stock will make a lot of money in the future over the time in ST/NT/LT.
Sep 22, 26 · entry 5 · open · 29d
Someday you will regret not loading up as many as you could have at around $5. This is going to be in $15 - $50 range within next 3 yrs.
Sep 22, 26 · entry 2.5287 · open · 29d
Will for sure see between $3 - $7 in ST and with PAYtience in NT it will likely be seen at $5 - $15.
Sep 22, 26 · entry 0.45 · open · 29d
Undiscovered gem. Owns 163,000 shares of SpaceX (bought years ago at very low pre-IPO prices at average cost ~$20/share). Holds a large quantity of Bitcoins bought at $33,600 average. Portfolio also includes Solana. Recent strong rally in both key holdings makes this an attractive buy. Recently Neptune expanded AI and Robotics Exposure with Strategic Investment of $500k in privately owned venture Atoms led by Travis Kalanick, co-founder and former CEO of Uber. Do your DD on the company and if you like it, grab some at current attractive price and add on dips. | If you can't afford to own shares of SpaceX & own Bitcoin, here's a way to have exposure with small investment. They also have invested in Atoms recently which will be a high flier down the road. Do your DD on this company and start loading up if you like it for ST/NT & LT.
Sep 21, 26 · entry 0.011 · open · 30d
In about next 10 days we should be hearing about completion of 2025 audits. Uplisting process therafter shortly with SEC registration filing. New mining operations and expansions ongoing which should increase Gold production going forward. Now is a great time to add more at dirt cheap current prices or to start a new long position if you have not so far in this chepeast penny gold miner that is growing fast and is highly profitable imo.
Sep 11, 26 · entry 9 · open · 40d
Below $9 looks like a great buy at current dirt cheap valuation given they do most of their work for DELL.
Sep 11, 26 · entry 4.575 · open · 40d
Loading up on dips. Nasdaq listed Founder Group Ltd is Malaysia's leading Solar and Renewable energy company. Super thin float of <35,000 shares. Current market cap is very low. Company has been winning many solar installation contracts and is eyeing US $3.2B-$3.7B contracts. Entry zone $4.50-$4.65 in pre-market.
This is your record?
Claim it, free.
Dispute a call → · How to score higher →
ANTE is a record of public calls and their market outcomes — not financial advice, and never a recommendation to follow or trade with anyone.